You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-ADAMTS13 antibody (ab72075)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-ADAMTS13 antibody
See all ADAMTS13 products (8) ...

Description

Rabbit polyclonal to ADAMTS13

Tested applications

IPmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide corresponding to a region between residue 150 and 200 of human ADAMTS13 (according to NP_620594.1)

Positive control

Human serum

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

Preservative: 0.09% Sodium Azide
Constituents: 8mM PBS, 60mM Citrate, 150mM Tris, pH 7 to 8

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

Applications

Show applications key

Our Abpromise guarantee covers the use of ab72075 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

Is unsuitable for or WB.

Target

Function

Cleaves the vWF multimers in plasma into smaller forms.

Tissue specificity

Plasma. Expressed primarily in liver.

Involvement in disease

Defects in ADAMTS13 are the cause of thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150]; also known as Upshaw-Schulman syndrome (USS). A hematologic disease characterized by hemolytic anemia with fragmentation of erythrocytes, thrombocytopenia, diffuse and non-focal neurologic findings, decreased renal function and fever.

Sequence similarities

Contains 2 CUB domains.
Contains 1 disintegrin domain.
Contains 1 peptidase M12B domain.
Contains 8 TSP type-1 domains.

Domain

The pro-domain is not required for folding or secretion and does not perform the common function of maintening enzyme latency.
The spacer domain is necessary to recognize and cleave vWF. The C-terminal TSP type-1 and CUB domains may modulate this interaction.

Post-translational
modifications

May contain a C-mannosylation site and O-fucosylation sites in the TSP type-1 domains.
The precursor is processed by a furin endopeptidase which cleaves off the pro-domain.

Cellular localization

Secreted.

Target information above from: UniProt accessionQ76LX8 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Von Willebrand factor cleaving protease antibody
  • A disintegrin and metalloproteinase with thrombospondin motifs 13 antibody
  • A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 13 antibody
  • A disintegrin like and metalloprotease with thrombospondin type 1 motif 13 antibody
  • ADAM metallopeptidase with thrombospondin type 1 motif 13 antibody
  • ADAM TS 13 antibody
  • ADAM TS13 antibody
  • ADAM-TS 13 antibody
  • ADAM-TS13 antibody
  • ADAMTS 13 antibody
  • ADAMTS-13 antibody
  • ADAMTS13 antibody
  • ADAMTS13 protein antibody
  • ATS13_HUMAN antibody
  • C9orf8 antibody
  • DKFZp434C2322 antibody
  • EC 3.4.24. antibody
  • FLJ42993 antibody
  • MGC118899 antibody
  • MGC118900 antibody
  • TTP antibody
  • von Willebrand factor-cleaving protease antibody
  • vWF cleaving protease antibody
  • vWF CP antibody
  • vWF-cleaving protease antibody
  • vWF-CP antibody
  • vWFCP antibody
see all

References for Anti-ADAMTS13 antibody (ab72075)

ab72075 has not yet been referenced specifically in any publications.

Publishing research using ab72075? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"